MESANTOIN Drug Patent Profile
✉ Email this page to a colleague
When do Mesantoin patents expire, and what generic alternatives are available?
Mesantoin is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in MESANTOIN is mephenytoin. Additional details are available on the mephenytoin profile page.
Summary for MESANTOIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Patent Applications: | 2,460 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MESANTOIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MESANTOIN
US Patents and Regulatory Information for MESANTOIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | MESANTOIN | mephenytoin | TABLET;ORAL | 006008-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |